As of August 2025, FTI's trailing twelve months (TTM) EPS stands at $2.15, according to the latest financial reports. In 2024, the company recorded an earnings per share (EPS) of $1.96, which represents an increase compared to its EPS of $0.13 in 2023. FTI reported an EPS of $0.65 for the quarterly report ending on Jun 30, 2025.
For 2024, TechnipFMC's EPS was $1.96, an increase of 1,407.7% from $0.13 in 2023. For the quarter ending Jun 30, 2025, the EPS was $0.65, showing a 51.2% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of June 2025 is $2.15. In 2023, the annual EPS was $0.13, showing an increase of 154.2% from 2022.
Over the last 12 months, TechnipFMC has registered an EPS growth of 51.2% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of 302.8% per year over the past 3 years. A 10-year view shows that FTI has seen an average EPS growth of -7.5% per year.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
INVX Innovex International Inc. | 7.74 | 18% | N/A | 124% |
NOV National Oilwell Varco Inc | 10.12 | -36% | N/A | N/A |
SLB Schlumberger Limited | 11.24 | 6.4% | 32.8% | N/A |
FTI TechnipFMC plc | 16.56 | 1,407.7% | 302.8% | N/A |
GE General Electric Co | 37.32 | -28.4% | N/A | N/A |
OIS Oil States International Inc | 45.82 | -190% | N/A | N/A |
FET Forum Energy Technologies Inc | N/A | -494.6% | N/A | N/A |
BOLT Bolt Biotherapeutics Inc | N/A | 9.8% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.